Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient.

Phillips KG, Velasco CR, Li J, Kolatkar A, Luttgen M, Bethel K, Duggan B, Kuhn P, McCarty OJ.

Front Oncol. 2012 Jul 18;2:72. doi: 10.3389/fonc.2012.00072. eCollection 2012.

2.

Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient.

Phillips KG, Kolatkar A, Rees KJ, Rigg R, Marrinucci D, Luttgen M, Bethel K, Kuhn P, McCarty OJ.

Front Oncol. 2012 Aug 9;2:96. doi: 10.3389/fonc.2012.00096. eCollection 2012.

3.

Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

Wendel M, Bazhenova L, Boshuizen R, Kolatkar A, Honnatti M, Cho EH, Marrinucci D, Sandhu A, Perricone A, Thistlethwaite P, Bethel K, Nieva J, Heuvel Mv, Kuhn P.

Phys Biol. 2012 Feb;9(1):016005. doi: 10.1088/1478-3967/9/1/016005. Epub 2012 Feb 3.

4.

mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.

Mostert B, Sieuwerts AM, Bolt-de Vries J, Kraan J, Lalmahomed Z, van Galen A, van der Spoel P, de Weerd V, RamĂ­rez-Moreno R, Smid M, Verhoef C, IJzermans JN, Gratama JW, Sleijfer S, Foekens JA, Martens JW.

Mol Oncol. 2015 Apr;9(4):920-32. doi: 10.1016/j.molonc.2015.01.001. Epub 2015 Jan 21.

5.

Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.

Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M.

Breast Cancer Res Treat. 2015 Dec;154(3):563-71. doi: 10.1007/s10549-015-3636-4. Epub 2015 Nov 16.

PMID:
26573830
6.

Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.

Shiomi-Mouri Y, Kousaka J, Ando T, Tetsuka R, Nakano S, Yoshida M, Fujii K, Akizuki M, Imai T, Fukutomi T, Kobayashi K.

Breast Cancer. 2016 Jan;23(1):120-7. doi: 10.1007/s12282-014-0539-x. Epub 2014 Jun 7.

PMID:
24906662
7.
8.

Classification of circulating tumor cells by epithelial-mesenchymal transition markers.

Wu S, Liu S, Liu Z, Huang J, Pu X, Li J, Yang D, Deng H, Yang N, Xu J.

PLoS One. 2015 Apr 24;10(4):e0123976. doi: 10.1371/journal.pone.0123976. eCollection 2015.

9.

Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.

Blassl C, Kuhlmann JD, Webers A, Wimberger P, Fehm T, Neubauer H.

Mol Oncol. 2016 Aug;10(7):1030-42. doi: 10.1016/j.molonc.2016.04.002. Epub 2016 Apr 20.

10.

Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers.

Marrinucci D, Bethel K, Kolatkar A, Luttgen MS, Malchiodi M, Baehring F, Voigt K, Lazar D, Nieva J, Bazhenova L, Ko AH, Korn WM, Schram E, Coward M, Yang X, Metzner T, Lamy R, Honnatti M, Yoshioka C, Kunken J, Petrova Y, Sok D, Nelson D, Kuhn P.

Phys Biol. 2012 Feb;9(1):016003. doi: 10.1088/1478-3975/9/1/016003. Epub 2012 Feb 3.

11.

High-purity and label-free isolation of circulating tumor cells (CTCs) in a microfluidic platform by using optically-induced-dielectrophoretic (ODEP) force.

Huang SB, Wu MH, Lin YH, Hsieh CH, Yang CL, Lin HC, Tseng CP, Lee GB.

Lab Chip. 2013 Apr 7;13(7):1371-83. doi: 10.1039/c3lc41256c.

PMID:
23389102
12.

Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.

Das A, Kunkel M, Joudeh J, Dicker DT, Scicchitano A, Allen JE, Sarwani N, Yang Z, Kaifi J, Zhu J, Liao J, El-Deiry WS.

Cancer Biol Ther. 2015;16(5):709-13. doi: 10.1080/15384047.2015.1030555.

13.

Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M.

Nature. 2007 Dec 20;450(7173):1235-9.

14.

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.

He W, Kularatne SA, Kalli KR, Prendergast FG, Amato RJ, Klee GG, Hartmann LC, Low PS.

Int J Cancer. 2008 Oct 15;123(8):1968-73. doi: 10.1002/ijc.23717.

15.

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.

Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H.

Breast Cancer Res Treat. 2017 Jan;161(1):83-94. doi: 10.1007/s10549-016-4026-2. Epub 2016 Oct 22.

PMID:
27771841
16.

Expected clinical applications of circulating tumor cells in breast cancer.

Park Y, Kitahara T, Urita T, Yoshida Y, Kato R.

World J Clin Oncol. 2011 Aug 10;2(8):303-10. doi: 10.5306/wjco.v2.i8.303.

17.

Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.

Hughes AD, Mattison J, Western LT, Powderly JD, Greene BT, King MR.

Clin Chem. 2012 May;58(5):846-53. doi: 10.1373/clinchem.2011.176669. Epub 2012 Feb 16.

18.

Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.

Fan T, Zhao Q, Chen JJ, Chen WT, Pearl ML.

Gynecol Oncol. 2009 Jan;112(1):185-91. doi: 10.1016/j.ygyno.2008.09.021. Epub 2008 Oct 26.

19.

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.

Liu JF, Kindelberger D, Doyle C, Lowe A, Barry WT, Matulonis UA.

Gynecol Oncol. 2013 Nov;131(2):352-6. doi: 10.1016/j.ygyno.2013.08.006. Epub 2013 Aug 13.

PMID:
23954902
20.

Proportion of circulating tumor cell clusters increases during cancer metastasis.

Suo Y, Xie C, Zhu X, Fan Z, Yang Z, He H, Wei X.

Cytometry A. 2017 Mar;91(3):250-253. doi: 10.1002/cyto.a.23037. Epub 2016 Dec 23.

PMID:
28009470

Supplemental Content

Support Center